Kristine Holgersen

Research output

Research output per year 2012 2014 2015 2018

• 6 Journal article
• 2 Poster

Research output per year

Research output per year

Search results

• 2018

  Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease

  Lindebo Holm, T., Tornehave, D., Søndergaard, H., Kvist, P. H., Sondergaard, B-C., Hansen, L., Hermit, M. B., Holgersen, K., Vergo, S., Frederiksen, K. S., Haase, C. & Lundsgaard, D., 10 Apr 2018, In: Gastroenterology Research and Practice. 2018, 22 p., 5962624.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • interleukin-21 100%
  • Crohn Disease 69%
  • T-Lymphocytes 35%
  • Colitis 29%
  • Therapeutics 11%
  7 Citations (Scopus)

  71 Downloads (Pure)
• 2015

  High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis

  Holgersen, K., Kutlu, B., Fox, B., Serikawa, K., Lord, J., Hansen, A. K. & Holm, T. L., 1 Jun 2015, In: Journal of Crohn's and Colitis (JCC). 9, 6, p. 492-506 15 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • RNA Sequence Analysis 100%
  • Gene Expression Profiling 92%
  • Colitis 91%
  • Inflammatory Bowel Diseases 84%
  • Interleukin-10 39%
  33 Citations (Scopus)

• Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice

  Holgersen, K., Dobie, R., Farquharson, C., Van't Hof, R., Ahmed, S. F., Hansen, A. K. & Lindebo Holm, T., Feb 2015, In: Inflammatory Bowel Diseases. 21, 2, p. 257-266 10 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Piroxicam 100%
  • Knockout Mice 66%
  • Interleukin-10 64%
  • Bone and Bones 43%
  • Colitis 42%
  7 Citations (Scopus)
• 2014

  Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse: a model mimicking inflammatory bowel disease

  Holgersen, K., Kvist, P. H., Markholst, H., Hansen, A. J. K. & Holm, T. L., 1 Feb 2014, In: Journal of Crohn's and Colitis. 8, 2, p. 147-160 14 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Piroxicam 100%
  • Enterocolitis 99%
  • Inflammatory Bowel Diseases 68%
  • Knockout Mice 66%
  • Interleukin-10 64%
  24 Citations (Scopus)

• IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis

  Seidelin, J. B., Coskun, M., Kvist, P. H., Holm, T. L., Holgersen, K. & Nielsen, O. H., Feb 2014, In: Journal of Gastroenterology. 50, 2, p. 180-190 11 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Interleukin-33 100%
  • Ulcerative Colitis 72%
  • T-Lymphocytes 45%
  • Colitis 26%
  • Piroxicam 14%
  37 Citations (Scopus)

• Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice

  Holgersen, K., Kvist, P. H., Hansen, A. J. K. & Holm, T. L., Jul 2014, In: International Immunopharmacology. 21, 1, p. 137-147 11 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  7 Citations (Scopus)

• Validation of Piroxicam-Accelerated Colitis in the Interleukin-10 Knock out Mouse - a Preclinical Model Mimicking Human Inflammatory Bowel Disease

  Holgersen, K., Kvist, P. H., Hansen, A. J. K. & Holm, T. L., May 2014.

  Research output: Contribution to conference › Poster › Research › peer-review

  585 Downloads (Pure)
• 2012

  Evaluation of the piroxicam-accelerated interleukin-10 knock out mouse: - As a model of human inflammatory bowel disease.

  Holgersen, K., Kvist, P. H., Hansen, A. J. K. & Holm, T. L., Sept 2012.

  Research output: Contribution to conference › Poster › Research › peer-review